ALLR Reports Earnings Tomorrow: What to Expect
Allarity Therapeutics reports Q1 2026 earnings May 9th with analysts expecting a $0.22 EPS loss. Focus on clinical progress, cash runway, and DRP platform updates.
Allarity Therapeutics reports Q1 2026 earnings May 9th with analysts expecting a $0.22 EPS loss. Focus on clinical progress, cash runway, and DRP platform updates.
US futures mixed as Iran war tensions weigh on energy stocks. Asian markets decline on oil volatility while UK political…
Nikkei 225 fell 0.75% to ¥38,216 as US-Iran tensions sparked tech selloff, with Sony down 4.05% and Nintendo declining 3.92%…
Tokyo opens Friday amid US-Iran tensions. Wall Street fell overnight with S&P 500 down 0.31%. Energy stocks and safe-haven plays…
Intensity Therapeutics Inc (INTS) reported second-quarter 2026 earnings that beat analyst expectations, posting a loss of $0.96 per share compared…
Turning Point Brands Inc (TPB) delivered a solid earnings beat for Q2 2026, reporting adjusted earnings per share of $0.76…
GCI Liberty Inc (GLIBA) delivered disappointing second-quarter 2026 results, reporting earnings per share of $0.45 versus analyst expectations of $1.25,…
MarketWise Inc (MKTW) reported a significant earnings miss for Q2 2026, posting a loss of $0.23 per share against analyst…
SPY fell 0.31% as Iran war concerns drove selling in energy and materials sectors, while $7B in oil bets highlighted…
Ubiquiti Inc. reports earnings May 8, 2026, with analysts expecting $4.42 EPS on $840M revenue. Key focus on networking demand…